Scoop: Empower Pharmacy seeks financial partner – Axios

Share Article

Empower Pharmacy, a Houston-based compounding pharmacy targeting integrated health and wellness, is seeking an investment, sources tell Axios.
Why it matters: Private equity has a reputation for being acquisitive in compounding pharmacy — and Empower's growth profile and attractive end-markets suggest the asset will likely draw strong interest.
Driving the news: The founder-run company has mandated Cantor Fitzgerald for financial advice, with outreach to financial sponsors kicking off early this week, sources say.
By the numbers: The company, growing at a more than 30% clip over the last three years, is marketing close to $160 million of run-rate revenue off of EBITDA in the low $30 million range, sources say.
Details: Empower is seeking capital to fund the development of a new 503B facility that will substantially increase its growth trajectory and capacity over the next decade, one source says.
How it works: Empower, founded in 2009 by CEO Shaun Noorian, provides compounding pharmacy solutions for various health and wellness end-markets.
State of play: Empower is unique in its end-market focus areas, but private equity participation in the compounding pharmacy arena isn't new. In notable activity…
💭 Our thought bubble: Considering Bain's seven-year plus hold, QuVa also looks ripe for potential picking.
Empower did not immediately return a request for comment, while Cantor declined to comment.


You might also like

Surviving 2nd wave of corona

Surviving The 2nd Wave of Corona

‘This too shall pass away’ this famous Persian adage seems to be defeating us again and again in the case of COVID-19. Despite every effort